ACCURETIC

This brand name is authorized in United States. It is also authorized in Australia, Canada, Ireland, Italy, New Zealand, UK.

Active ingredients

The drug ACCURETIC contains a combination of these active pharmaceutical ingredients (APIs):

1	Quinapril UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE
	Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.
	Read more about Quinapril
2	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09BA06	Quinapril and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09B ACE inhibitors, combinations → C09BA ACE inhibitors and diuretics
Discover more medicines within C09BA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8589C, 8590D
CA	Health Products and Food Branch	02237367, 02237368, 02237369
GB	Medicines & Healthcare Products Regulatory Agency	140360, 161332, 26056
IE	Health Products Regulatory Authority	10092
IT	Agenzia del Farmaco	028295018
NZ	Medicines and Medical Devices Safety Authority	9643, 9644
US	FDA, National Drug Code	0071-0220, 0071-0222, 0071-0223